Tapanainen J - Search Results

1

[Anti-Müllerian hormone - a marker of ovarian function].

Koskela S, Tapanainen J. Koskela S, et al. Among authors: tapanainen j. Duodecim. 2016;132(3):226-32. Duodecim. 2016. PMID: 26951026 Review. Finnish.

2

The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.

Färkkilä A, Koskela S, Bryk S, Alfthan H, Bützow R, Leminen A, Puistola U, Tapanainen JS, Heikinheimo M, Anttonen M, Unkila-Kallio L. Färkkilä A, et al. Int J Cancer. 2015 Oct 1;137(7):1661-71. doi: 10.1002/ijc.29532. Epub 2015 Apr 11. Int J Cancer. 2015. PMID: 25808251

3

Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.

Pinola P, Morin-Papunen LC, Bloigu A, Puukka K, Ruokonen A, Järvelin MR, Franks S, Tapanainen JS, Lashen H. Pinola P, et al. Among authors: tapanainen js. Hum Reprod. 2014 Oct 10;29(10):2317-25. doi: 10.1093/humrep/deu182. Epub 2014 Jul 23. Hum Reprod. 2014. PMID: 25056088 Free PMC article.

4

Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.

Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L. Sova H, et al. Gynecol Endocrinol. 2019 Jul;35(7):595-600. doi: 10.1080/09513590.2018.1559807. Epub 2019 Jan 22. Gynecol Endocrinol. 2019. PMID: 30668196 Free article.

5

Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.

Kallio S, Aittomäki K, Piltonen T, Veijola R, Liakka A, Vaskivuo TE, Dunkel L, Tapanainen JS. Kallio S, et al. Among authors: tapanainen js. Hum Reprod. 2012 Mar;27(3):854-60. doi: 10.1093/humrep/der473. Epub 2012 Jan 17. Hum Reprod. 2012. PMID: 22258659

6

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Piltonen T, et al. Hum Reprod. 2005 Jul;20(7):1820-6. doi: 10.1093/humrep/deh850. Epub 2005 Mar 31. Hum Reprod. 2005. PMID: 15802325

7

[Andropause].

Tapanainen J. Tapanainen J. Duodecim. 2001;117(19):1974-9. Duodecim. 2001. PMID: 12181929 Review. Finnish. No abstract available.

8

Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls.

Kuiri-Hänninen T, Kallio S, Seuri R, Tyrväinen E, Liakka A, Tapanainen J, Sankilampi U, Dunkel L. Kuiri-Hänninen T, et al. Among authors: tapanainen j. J Clin Endocrinol Metab. 2011 Nov;96(11):3432-9. doi: 10.1210/jc.2011-1502. Epub 2011 Sep 7. J Clin Endocrinol Metab. 2011. PMID: 21900380

9

[Hormone-dependent cell death].

Tapanainen J. Tapanainen J. Duodecim. 1994;110(10):933-5. Duodecim. 1994. PMID: 7588101 Review. Finnish. No abstract available.

10

[Do men need follicle-stimulating hormone?].

Huhtaniemi I, Aittomäki K, de la Chapelle A, Tapanainen J. Huhtaniemi I, et al. Among authors: tapanainen j. Duodecim. 1997;113(6):465-6. Duodecim. 1997. PMID: 11370067 Finnish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters